1 |
Zhu C, Zhao Y, Zheng W. CDC14B is a favorable biomarker for recurrence and prognosis of GBM. Clin Neurol Neurosurg 2023;227:107665. [PMID: 36898299 DOI: 10.1016/j.clineuro.2023.107665] [Reference Citation Analysis]
|
2 |
Gabelloni M, Faggioni L, Fusco R, Simonetti I, De Muzio F, Giacobbe G, Borgheresi A, Bruno F, Cozzi D, Grassi F, Scaglione M, Giovagnoni A, Barile A, Miele V, Gandolfo N, Granata V. Radiomics in Lung Metastases: A Systematic Review. J Pers Med 2023;13. [PMID: 36836460 DOI: 10.3390/jpm13020225] [Reference Citation Analysis]
|
3 |
Trifănescu OG, Trifănescu RA, Mitrică R, Mitrea D, Ciornei A, Georgescu M, Butnariu I, Galeș LN, Șerbănescu L, Anghel RM, Păun MA. Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System. Diagnostics (Basel) 2023;13. [PMID: 36673007 DOI: 10.3390/diagnostics13020197] [Reference Citation Analysis]
|
4 |
Kim YI, Shin JY, Yang SH, Kim HH, Shim BY, Ahn S. Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis. Curr Oncol 2022;29:6463-71. [PMID: 36135077 DOI: 10.3390/curroncol29090508] [Reference Citation Analysis]
|